Pivotal role of cathepsin K in lung fibrosis

American Journal of Pathology

Volumn 164, Issue 6, 2004, Pages 2203-2216

  Bühling, Frank ^a   Röcken, Christoph ^a   Brasch, Frank ^b   Hartig, Roland ^a   Yasuda, Yoshiyuki ^d   Saftig, Paul ^c   Brömme, Dieter ^d   Welte, Tobias ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CATHEPSIN K; COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; DISEASE ACTIVITY; EMPHYSEMA; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 2442694270     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63777-7     Document Type: Article

References (54)

1. Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998, 157:1301-1315
2. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, et al: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995, 8:1398-1420
3. Senior RM, Anthonisen NR: Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 1998, 157:S139-S147
4. Davis PB, Drumm M, Konstan MW: Cystic fibrosis. Am J Respir Crit Care Med 1996, 154:1229-1256
5. Jindal SK, Gupta D: Incidence and recognition of interstitial pulmonary fibrosis in developing countries. Curr Opin Pulm Med 1997, 3:378-383
6. Nagai A: Pathology and pathophysiology of chronic obstructive pulmonary disease. Intern Med 2002, 41:265-269
7. Eickelberg O, Kohler E, Reichenberger F, Bertschin S, Woodtli T, Erne P, Perruchoud AP, Roth M: Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol 1999, 276:L814-L824
8. Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Bromme D: Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum 2002, 46:663-674
9. Chambers RC, Laurent JL: Collagens. The Lung. Edited by RG Crystal, JB West, ER Weibel, PJ Barnes. Philadelphia, Lippencott-Raven, 2003, pp 709-727
10. Zhang K, Phan SH: Cytokines and pulmonary fibrosis. Biol Signals 1996, 5:232-239
11. Ward PA, Hunninghake GW: Lung inflammation and fibrosis. Am J Respir Crit Care Med 1998, 157:S123-S129
12. Corbel M, Belleguic C, Boichot E, Lagante V: Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol 2002, 18:51-61
13. Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ, Travis WD: Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996, 149:1241-1256
14. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N: Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metal loproteinase-2 in interstitial lung diseases. Lab Invest 1998, 78:687-698
15. Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, Pardo A: TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol 2000, 279: L562-L574
16. Corbel M, Caulet-Maugendre S, Germain N, Molet S, Lagente V, Boichot E: Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J Pathol 2001, 193:538-545
17. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben Dor A, Lollini L, Morris D, Kim Y, DeLustro B, Sheppard D, Pardo A, Selman M, Heller RA: Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 2002, 99:6292-6297
18. Kolb M, Bonniaud P, Galt T, Sime PJ, Kelly MM, Margetts PJ, Gauldie J: Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am J Respir Cell Mol Biol 2002, 27:141-150
19. Everts V, van der Zee E, Creemers L, Beertsen W: Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 1996, 28:229-245
20. Bienkowski RS, Gotkin MG: Control of collagen deposition in mammalian lung. Proc Soc Exp Biol Med 1995, 209:118-140
21. Chapman HA, Riese RJ, Shi GP: Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997, 59:63-88
22. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney M, Foged NT, Delmas PD, Delaissé JM: The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352
23. Gelb BD, Shi GP, Chapman HA, Desnick RJ: Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996, 273:1236-1238
24. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, Von Figura K: Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 1998, 95:13453-13458
25. Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, Weiss SJ: Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 2000, 192:789-800
26. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998, 102:576-583
27. Bühling F, Reisenauer A, Gerber A, Krüger S, Weber E, Brömme D, Roessner A, Ansorge S, Welte T, Röcken C: Cathepsin K - a marker of macrophage differentiation? J Pathol 2001, 195:375-382
28. Bühling F, Gerber A, Häckel C, Krüger S, Köhnlein T, Brömme D, Reinhold D, Ansorge S, Welte T: Expression of cathepsin K in lung epithelial cells. Am J Respir Cell Mol Biol 1999, 20:612-619
29. Röcken C, Stix B, Brömme D, Ansorge S, Roessner A, Bühling F: A putative role for cathepsin K in degradation of AA and AL amyloidosis. Am J Pathol 2001, 158:1029-1038
30. Diaz A, Willis AC, Sim RB: Expression of the proteinase specialized in bone resorption, cathepsin K, in granulomatous inflammation. Mol Med 2000, 6:648-659
31. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese Jr RJ, Chapman Jr HA, Shapiro SD, Elias JA: Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000, 106:1081-1093
32. Swaisgood CM, French EL, Noga C, Simon RH, Ploplis VA: The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 2000, 157:177-187
33. Laxer U, Lossos IS, Gillis S, Or R, Christensen TG, Goldstein RH, Breuer R: The effect of enoxaparin on bleomycin-induced lung injury in mice. Exp Lung Res 1999, 25:531-541
34. Creemers LB, Jansen DC, Veen-Reurings A, van den BT, Everts V: Microassay for the assessment of low levels of hydroxyproline. Bio-Techniques 1997, 22:656-658
35. Weber E, Bahn H, Günther D: Monoclonal antibodies against cathepsin L and procathepsin L of different species. Hybridoma 1997, 16:159-166
36. Bromme D, Okamoto K, Wang BB, Biroc S: Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 1996, 271:2126-2132
37. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, Gores GJ: Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003, 112:152-159
38. Tournu C, Obled A, Roux MP, Deval C, Ferrara M, Béchet DM: Glucose controls cathepsin expression in ras-transformed fibroblasts. Arch Biochem Biophys 1998, 360:15-24
39. Barrett AJ, Kirschke H: Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 1981, 80:535-561
40. Aibe K, Yazawa H, Abe K, Teramura K, Kumegawa M, Kawashima H, Honda K: Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol Pharm Bull 1996, 19:1026-1031
41. Fehrenbach H, Ochs M: Studying lung ultrastructure. Methods in Pulmonary Research. Edited by S Uhling, AE Tayllor. Basel, Birkhäuser, 1998, pp 429-454
42. Peterkofsky B, Diegelmann R: Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1971, 10:988-994
43. Agelli M, Wahl SM: Collagen production by fibroblasts. Methods Enzymol 1988, 52:642-656
44. Hummel KM, Petrow PK, Franz JK, Müller-Ladner U, Aicher WK, Gay RE, Brömme D, Gay S: Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 1998, 25:1887-1894
45. Hou WS, Li Z, Gordon RE, Chan K, Klein MJ, Levy R, Keysser M, Keyszer G, Bromme D: Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation. Am J Pathol 2001, 159:2167-2177
46. Honey K, Benlagha K, Beers C, Forbush K, Teyton L, Kieijmeer MJ, Rudensky AY, Bendelac A: Thymocyte expression of cathepsin L is essential for NKT cell development. Nat Immunol 2002, 3:1069-1074
47. Lynch III JP, White E, Flaherty K: Corticosteroids in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2001, 7:298-308
48. Collard HR, King Jr TE: Treatment of idiopathic pulmonary fibrosis: the rise and fall of corticosteroids. Am J Med 2001, 110:326-328
49. Nagase T, Uozumi N, Ishii S, Kita Y, Yamamoto H, Ohga E, Ouchi Y, Shimizu T: A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis. Nat Med 2002, 8:480-484
50. Berg RA, Schwartz ML, Crystal RG: Regulation of the production of secretory proteins: intracellular degradation of newly synthesized "defective" collagen. Proc Natl Acad Sci USA 1980, 77:4746-4750
51. Lee W, Sodek J, McCulloch CA: Role of integrins in regulation of collagen phagocytosis by human fibroblasts. J Cell Physiol 1996, 168:695-704
52. Everts V, Hou WS, Rialland X, Tigchelaar W, Saflig P, Bromme D, Gelb BD, Beertsen W: Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts. Calcif Tissue Int 2003, 73:380-386
53. Yamashita DS, Dodds RA: Cathepsin K and the design of inhibitors of cathepsin K. Curr Pharm Des 2000, 6:1-24
54. Li Z, Hou WS, Escalante-Torres CR, Gelb BD, Bromme D: Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J Biol Chem 2002, 277:28669-28676